The Insider: Community Edition - August 2023
Featured News
New deep tech startup creator Embark announces first cohort of entrepreneurs
The Embark Deep Tech Startup Creator at Venture Partners at CU Â鶹ӰԺ has officially launched its first Embark Entrepreneurs in Residence cohort. Embark aims to connect business minds outside the university with breakthrough inventions emerging from CU Â鶹ӰԺ's research labs to bring them to market and unleash the full impact of CU Â鶹ӰԺ's research into the world.
CU Â鶹ӰԺ partners on CO-WY Engine named finalist in NSF Regional Innovation Competition
Innosphere Ventures—CU Â鶹ӰԺ is one of the partner universities in the Colorado-Wyoming Engine proposal, a finalist in the National Science Foundation's (NSF) Regional Innovation Engines competition. The proposal aims to address climate solutions and community resiliency, competing for up to $160 million in funding over the next ten years.
CU Â鶹ӰԺ Startups and Innovations in the News
Meati Foods teams up with Whole Foods to launch its plant-based products nationwide
Denver Post—Meati Foods, a Â鶹ӰԺ-based producer of plant-based meat alternatives and CU Â鶹ӰԺ spinout, is expanding its commercial reach by selling to Whole Foods Markets across the country.
Physicist-turned-engineer earns international recognition for quantum contributions
College of Engineering and Applied Science—Svenja Knappe and her colleagues have developed a helmet that contains 128 sensors and is customizable for different sizes of the human head. Knappe founded the Â鶹ӰԺ-based company FieldLine and has begun to bring these sensors to market. In the not-so-distant future, they could aid in the diagnosis and treatment of a wide range of neurological conditions like epilepsy, autism and traumatic brain injuries.
VitriVax wins $29M Department of Defense contract for vaccine research
BizWest—VitriVax Inc., a Â鶹ӰԺ-based developer of vaccine-shot technology and CU Â鶹ӰԺ spinout, was recently awarded a five-year, $29 million contract from the U.S. Department of Defense to create a single-injection, thermostable vaccine for melioidosis and glanders.
New Iridium secures $1M NSF SBIR Phase II grant
Innosphere Ventures—New Iridium, a CU Â鶹ӰԺ spinoutÌýdedicated to decarbonizing the chemical industry and driving sustainable innovation, announced it has been awarded a $1 million National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase II grant.ÌýThis grant will enable New Iridium to advance its cutting-edge photocatalysis platform that uses light rather than heat, revolutionizing the production of low-carbon chemicals while significantly reducing costs compared to today’s processes.
When it comes to treating resistant breast cancer, 2 drugs may be better than 1
CU Â鶹ӰԺ Today—In 2016, Pfizer began collaborating with Sabrina Spencer, a global leader in time-lapse cell imaging and member of the CU Cancer Center, to study how cancer cells respond to their potent new drugs called CDK2 inhibitors.